Washington: International media reported on Tuesday that a new two-minute COVID-19 test has been approved for use by the U.S. Food and Drug Administration (FDA).
According to Business Wire, Bodysphere Inc., based in Los Angeles, announced it will be dispensing two-minute test kits for diagnosing new coronaviruses after the FDA reports the green emergency licensed signal.
The game-changing two-minute test has “a 91% clinical specificity rate and a 99% clinical sensitivity rate” and delivers results “on site in as fast as two minutes”, the publication added.
Reuters quoted Bodysphere by saying that it is working with the Trump administration and the state government to bring the test (for emergencies) to the frontline.
US President Donald Trump praised the “excellent” drug regulator, he said on March 19 that he urged the FDA to approve similar tests and drugs for COVID-19 panic attacks. To date, the United States has registered more than 3,000 pandemic deaths.
Last week, the agency approved a test from Abbott Laboratories, which can produce results in five minutes.